SMN2 and proximal spinal muscular atrophy: Ninety-five percent of SMA patients have a homozygous deletion of exon 7 of SMN1 or gene conversion from SMN1 to SMN2 (5q-SMA patients) [10], while the remaining 5% are compound heterozygotes for a deletion of exon 7 in SMN1 and a point mutation.